These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36535197)

  • 1. PCSK9: A emerging participant in heart failure.
    Xu Q; Zhao YM; He NQ; Gao R; Xu WX; Zhuo XJ; Ren Z; Wu CY; Liu LS
    Biomed Pharmacother; 2023 Feb; 158():114106. PubMed ID: 36535197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCSK9 regulates pyroptosis via mtDNA damage in chronic myocardial ischemia.
    Wang X; Li X; Liu S; Brickell AN; Zhang J; Wu Z; Zhou S; Ding Z
    Basic Res Cardiol; 2020 Nov; 115(6):66. PubMed ID: 33180196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis identifies PCSK9 as a prognosticator correlated with lipid metabolism in pancreatic adenocarcinoma.
    Zhou S; Guo Q; Chen A; Li X; Zou X
    World J Surg Oncol; 2024 Sep; 22(1):256. PubMed ID: 39342295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy.
    Ding Z; Wang X; Liu S; Shahanawaz J; Theus S; Fan Y; Deng X; Zhou S; Mehta JL
    Cardiovasc Res; 2018 Nov; 114(13):1738-1751. PubMed ID: 29800228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCSK9: Associated with cardiac diseases and their risk factors?
    Guo Y; Yan B; Tai S; Zhou S; Zheng XL
    Arch Biochem Biophys; 2021 Jun; 704():108717. PubMed ID: 33307067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proprotein Convertase Subtilisin/Kexin-Type 9 and Lipid Metabolism.
    Guo S; Xia XD; Gu HM; Zhang DW
    Adv Exp Med Biol; 2020; 1276():137-156. PubMed ID: 32705598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and Function of Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in Hyperlipidemia and Atherosclerosis.
    Lu X
    Curr Drug Targets; 2019; 20(10):1029-1040. PubMed ID: 30767742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transient amphipathic helix in the prodomain of PCSK9 facilitates binding to low-density lipoprotein particles.
    Sarkar SK; Foo ACY; Matyas A; Asikhia I; Kosenko T; Goto NK; Vergara-Jaque A; Lagace TA
    J Biol Chem; 2020 Feb; 295(8):2285-2298. PubMed ID: 31949048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9.
    Seidah NG; Abifadel M; Prost S; Boileau C; Prat A
    Pharmacol Rev; 2017 Jan; 69(1):33-52. PubMed ID: 27920219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Is Detrimental to the Juvenile Host With Septic Shock.
    Atreya MR; Whitacre BE; Cvijanovich NZ; Bigham MT; Thomas NJ; Schwarz AJ; Weiss SL; Fitzgerald JC; Allen GL; Lutfi R; Nowak JE; Quasney MW; Shah AS; Wong HR
    Crit Care Med; 2020 Oct; 48(10):1513-1520. PubMed ID: 32769621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCSK9 regulates myofibroblast transformation through the JAK2/STAT3 pathway to regulate fibrosis after myocardial infarction.
    Bao H; Wang X; Zhou H; Zhou W; Liao F; Wei F; Yang S; Luo Z; Li W
    Biochem Pharmacol; 2024 Feb; 220():115996. PubMed ID: 38154546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood Levels of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Men from Different Population Groups and Its Relation to Unfavorable Long-Term Prognosis].
    Ragino YI; Astrakova KS; Shakhtshneider EV; Stakhneva EM; Gafarov VV; Bogatyrev SN; Voevoda MI
    Kardiologiia; 2017 Apr; 57(4):72-76. PubMed ID: 28762908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel angiogenic effect of PCSK9- regulated genes.
    Zhan X; Jiang L; Wang L; Liu J; Kang S; Liu H; Lin L
    Gene; 2023 Feb; 852():147051. PubMed ID: 36427678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropy of PCSK9: Functions in Extrahepatic Tissues.
    Şener YZ; Tokgözoğlu L
    Curr Cardiol Rep; 2023 Sep; 25(9):979-985. PubMed ID: 37428313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercholesterolemia: The role of PCSK9.
    Melendez QM; Krishnaji ST; Wooten CJ; Lopez D
    Arch Biochem Biophys; 2017 Jul; 625-626():39-53. PubMed ID: 28587771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.
    Jang HD; Lee SE; Yang J; Lee HC; Shin D; Lee H; Lee J; Jin S; Kim S; Lee SJ; You J; Park HW; Nam KY; Lee SH; Park SW; Kim JS; Kim SY; Kwon YW; Kwak SH; Yang HM; Kim HS
    Eur Heart J; 2020 Jan; 41(2):239-252. PubMed ID: 31419281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stepwise processing analyses of the single-turnover PCSK9 protease reveal its substrate sequence specificity and link clinical genotype to lipid phenotype.
    Chorba JS; Galvan AM; Shokat KM
    J Biol Chem; 2018 Feb; 293(6):1875-1886. PubMed ID: 29259136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCSK9: an emerging player in cardiometabolic aging and its potential as a therapeutic target and biomarker.
    Csiszar A; Tarantini S; Yabluchanskiy A; Ungvari Z
    Geroscience; 2024 Feb; 46(1):257-263. PubMed ID: 38105401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
    Qi Z; Hu L; Zhang J; Yang W; Liu X; Jia D; Yao Z; Chang L; Pan G; Zhong H; Luo X; Yao K; Sun A; Qian J; Ding Z; Ge J
    Circulation; 2021 Jan; 143(1):45-61. PubMed ID: 32988222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer.
    Bhattacharya A; Chowdhury A; Chaudhury K; Shukla PC
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188581. PubMed ID: 34144130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.